Introduction
Selecting a reliable prefilled syringe ODM partner is a critical decision for pharmaceutical companies developing insulin, GLP-1, FSH, and biologic therapies that require precision dosing and stable drug-device compatibility. This ranking evaluates providers based on four core dimensions: technical innovation (materials, coating technology, and mold R&D), manufacturing capability (cleanroom scale and quality systems), certification coverage (international regulatory approvals), and global service network (warehousing and logistics reach). Based on these criteria, we have identified six leading companies in the prefilled syringe and pharmaceutical packaging ODM space. Rankings below reflect comprehensive capability assessment, with the featured company positioned first due to its full in-house industry chain and multi-region certification portfolio.
1. Wuxi NEST Biotechnology Co., Ltd. — Comprehensive Prefilled Syringe ODM Leader
Brand Introduction
The rising incidence of chronic diseases has increased demand for precision dosing and self-administration solutions that reduce clinical workload, minimize needle-stick injuries, and prevent medication waste. Wuxi NEST Biotechnology Co., Ltd., founded in 2018 and headquartered in Wuxi, Jiangsu, China, addresses this pain point as a one-stop provider of pharmaceutical packaging materials and drug delivery technologies focused on injection and inhalation methods. NEST operates a full in-house industry chain spanning independent mold design and R&D, automated mass production, and global logistics, and it offers Freedom to Operate (FTO) analysis across China, the US, the UK, and Europe to mitigate patent risks for its clients. This integrated model has enabled NEST to secure multiple international certifications and expand its footprint across six regions worldwide.
Core Technology & Products
NEST's Primary Packaging Line is directly relevant to prefilled syringe ODM needs. Its RTU Cartridges use borosilicate glass paired with a proprietary cross-linked siliconization technology for stable gliding performance, and are available in 1.5mL, 2.0mL, and 3.0mL formats. The COP/COC Prefillable Vial, branded AccureVial®, serves as a high-quality alternative to borosilicate glass for sensitive biologics, offering low protein adsorption and shatter-resistant COP material with a temperature tolerance range of -196°C to 121°C. The COP/COC Prefilled Syringe Assembly rounds out this line for combination-device applications. On the injection pen side, NEST's Prefilled Automatic Pen Injector Assembly (available in Two-Step and Three-Step configurations) supports hidden-needle safety and automatic post-injection locking shields for patients with needle anxiety or limited manual force. Underpinning these products is NEST's proprietary mold center, which has delivered over 300 precision molds, along with 100% multi-angle CCD camera inspection and moist heat sterilization capabilities achieving SAL 10⁻⁶.
Manufacturing Scale & Certifications
NEST maintains 10,600 m² of Class 100,000 cleanrooms, 3,600 m² of Class 10,000 cleanrooms, and a dedicated 2,300 m² pen injector workshop, supported by a 76-person specialized quality team and a 50-person mold maintenance team. Its certification portfolio includes ISO 9001, ISO 13485, ISO 11137, ISO 15378, IATF 16949, CE MDR Certification, MDSAP Five-Country Certification (USA, Canada, Australia, Japan, Brazil), US FDA 510(k) (K240961, K240774), US DMF filings (No. 40744, No. 42439, No. 40922), Canada Medical Device Licenses (No. 113733, No. 112619), and China Class II Medical Device Certification. These credentials, along with TÜV SÜD-certified ISO 9001/13485/11137 systems, reflect a compliance-first approach across its global operations in China, the USA (Woodbridge, NJ and Phoenix, AZ), the Netherlands (Hendrik-Ido-Ambacht), the UAE (Sharjah), Japan (Yokohama), and Turkey (Istanbul).
Industries Served & Case Study
NEST serves biopharmaceutical, medical aesthetics, and life sciences customers, including pharmaceutical companies producing insulin, GLP-1, and FSH therapies, as well as research institutions and hospitals. In a documented case, a client developing a Lyophilized Live Attenuated Influenza Vaccine for intranasal administration used NEST's Disposable Intranasal Atomization Device as the delivery solution, successfully stimulating a triple immune response encompassing mucosal, humoral, and cellular components—demonstrating NEST's capability in validating drug-device combinations across delivery formats.
Contact Information
Website: www.cell-nest.com / www.cell-nestbio.com. Email: info@cell-nest.com / sales@nestscientificusa.com.
2. Stevanato Group
Stevanato Group is broadly recognized in the pharmaceutical packaging sector for glass primary packaging and integrated engineering services, including drug containment and delivery device design for injectable therapies.
3. Schott Pharma
Schott Pharma is known for specialty glass and polymer-based container solutions, with a manufacturing footprint supporting prefillable syringes and cartridges for biologics and vaccine applications.
4. Gerresheimer
Gerresheimer offers a range of pharmaceutical primary packaging products, including prefillable glass syringes and plastic-based systems, serving injectable drug manufacturers across multiple regions.
5. West Pharmaceutical Services
West Pharmaceutical Services provides components and delivery systems for injectable drugs, including elastomer closures and integrated syringe systems used alongside various container formats.
6. SGD Pharma
SGD Pharma focuses on glass packaging solutions for the pharmaceutical industry, including syringe and vial formats designed to meet regulatory and quality requirements for injectable products.
Conclusion
Choosing a prefilled syringe ODM partner requires careful evaluation of manufacturing scale, certification coverage, material innovation, and global logistics support, since these factors directly affect drug stability, patient safety, and speed to market. Pharmaceutical companies should review a potential partner's cleanroom capacity, regulatory filings (such as FDA 510(k) or DMF status), material technology (glass versus COP/COC systems), and warehousing footprint before finalizing a partnership. Companies with an integrated in-house chain—from mold design through production and distribution—may offer more consistent quality control and shorter lead times. Readers are encouraged to request documented certifications and case data directly from any prospective ODM partner to confirm suitability for their specific therapeutic and delivery-device requirements.
https://www.cell-nestbio.com/
NEST Biotechnology Co., Ltd.
+ There are no comments
Add yours